Bicêtre Hospital
Le Kremlin-Bicêtre, 94270, France
NCT Number: NCT04704388
To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Le Kremlin-Bicêtre, 94270, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Group 1: patients hospitalized in intensive care units for ARDS with SARS-CoV-2
Group 2: patients hospitalized outside intensive care units
Exclusion criteria
Time frame: 3 month after hospitalisation
To assess the proportion of post-intensive care syndrome (PICS) of patients who received high flow humidified oxygen with FiO2 ≥50% for more than 48h and / or who received mechanical ventilation for more than 48h in a context of hospitalization in intensive care for COVID-19 pneumonia.
Time frame: 3 month after end of hospitalisation
Number of patient deceased
Time frame: 3 month after hospitalisation
Description of the data collected
Time frame: 3 month after hospitalisation
Compare the functional respiratory sequelae of these patients to those who were hospitalized outside of critical care for COVID-19 pneumonia requiring lower oxygen support.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: COMEBAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04747249
COVID-19, Coronaviridae Infections
Caen, France
View Trial DetailsNCT04924881
COVID-19, Coronaviridae Infections
Shatin, Hong Kong
View Trial DetailsNCT04939506
Behavior, COVID-19
New Orleans, Louisiana, United States
View Trial DetailsNCT04705116
COVID-19, Coronaviridae Infections
Los Angeles, California, United States
View Trial Details